Lung cancer therapy is 'milestone'
A lung cancer therapy can more than double life expectancy in some patients, a "milestone" trial shows. Nivolumab stops cancerous cells hiding from the body's own defences, leaving the cancer vulnerable to attack. The results from 582 people, presented ...
New immunotherapy drug outperforms chemotherapy for a form of lung cancer
Bristol's Opdivo cuts risk of lung cancer death for some
Immune system boosting drug outperformed chemotherapy in lung cancer study